Dr. Jean Michel Bolla is a distinguished researcher specializing in microbiology, biochemistry, and antibiotic resistance. With over 30 years of experience, he has made significant contributions to understanding bacterial resistance mechanisms, particularly efflux-mediated resistance in Gram-negative bacteria. As the Director of Research at Inserm U-1261, he has led pioneering studies in bacterial physiology and virulence, as well as the development of screening platforms for antibiotic-resistant bacteria. His leadership in the Bac-Screen platform, which enables high-throughput screening of antimicrobial compounds, highlights his commitment to innovative research. Dr. Bolla has supervised multiple PhD students and postdoctoral researchers, securing major research funding from national and international agencies. His work has been recognized through invited talks at international conferences and a patent related to diagnostic tools for antibiotic resistance. Additionally, he has contributed significantly to academia through teaching roles at Aix-Marseille Université and Université de Corse. His research continues to shape the field of antimicrobial resistance, addressing one of the most pressing global health challenges. Through his expertise, leadership, and dedication to scientific advancement, Dr. Bolla has established himself as a leading figure in microbiology and antibiotic resistance research.

Professional Profile

Education

Dr. Jean Michel Bolla holds a PhD in Biochemistry and Molecular Biology from UPR9027 CNRS, Marseille, awarded in 1990. His doctoral research focused on protein export and assembly in Escherichia coli, conducted under the supervision of Dr. JM Pagès. Following his PhD, he pursued a postdoctoral fellowship at Inserm-APHP, Paris, where he worked on iron starvation responses in Listeria monocytogenes under Dr. P. Berche. His advanced training includes specialization in Campylobacter porins at the Laboratory Centre for Disease Control in Ottawa and Winnipeg, Canada in 1997 and 1998. In 2001, he obtained his Habilitation à Diriger des Recherches (HDR) from the Faculty of Medicine, Timone, Marseille, enabling him to supervise doctoral research. His extensive academic training has provided him with a strong foundation in molecular microbiology, biochemistry, and antibiotic resistance. Through continuous education and research, Dr. Bolla has developed a deep understanding of bacterial physiology, antimicrobial resistance mechanisms, and drug discovery. His educational background has been instrumental in shaping his career as a leading researcher in microbiology and antibiotic resistance, allowing him to contribute groundbreaking insights to the field.

Professional Experience

Dr. Jean Michel Bolla has had an illustrious career in research, spanning over three decades. He began as a postdoctoral researcher at Inserm-APHP, Paris, before joining Inserm as a Chargé de Recherche in 1992. Over the years, he advanced within Inserm, holding key research positions, and became Director of Research at U-1261 in 2018. He has led major research initiatives, including the establishment of the Bac-Screen platform, a high-throughput screening system for antibiotic resistance studies. From 2007 to 2011, he also served as an Associate Professor at the Université de Corse, where he contributed significantly to teaching and student mentorship. Throughout his career, Dr. Bolla has supervised seven PhD students and three postdoctoral researchers, demonstrating his commitment to training future scientists. He has been an invited speaker at multiple international conferences, sharing his expertise in antibiotic resistance. His ability to secure major research funding, including grants from CNRS, ANR, and FEAMPA, underscores his impact in the field. His leadership roles at Inserm and collaborations with various research institutions have solidified his reputation as an expert in microbiology and antibiotic resistance.

Research Interest

Dr. Jean Michel Bolla’s research primarily focuses on antibiotic resistance mechanisms, with a particular emphasis on efflux-mediated resistance in Gram-negative bacteria. His work explores the physiology and virulence of bacterial pathogens, including Campylobacter jejuni and Listeria monocytogenes. He is deeply involved in drug discovery and screening technologies, having developed the Bac-Screen platform to identify novel antimicrobial compounds and assess their mechanisms of action. His research also extends to bacterial membrane permeability, studying how bacterial outer membrane porins influence antibiotic uptake and resistance. More recently, he has been engaged in synthetic antibacterial polymer development for therapeutic applications. His work contributes to understanding multidrug resistance mechanisms, a major global health challenge, and seeks innovative solutions to combat bacterial infections. Additionally, he collaborates on projects involving diagnostic tools for detecting antimicrobial resistance, aiming to improve early detection and treatment strategies. Through his research, Dr. Bolla strives to bridge the gap between basic microbiology and clinical applications, working towards the development of effective antimicrobial strategies to tackle the increasing threat of drug-resistant bacteria worldwide.

Research Skills

Dr. Jean Michel Bolla possesses a diverse range of research skills, with expertise in molecular microbiology, biochemistry, and antimicrobial resistance. He has extensive experience in protein purification, bacterial physiology studies, and genetic manipulation of bacterial pathogens. His work in high-throughput screening techniques has been pivotal in identifying new inhibitors for efflux pumps in Gram-negative bacteria. He is proficient in drug discovery methodologies, including antibiotic susceptibility testing, mode-of-action studies, and bacterial membrane permeability analysis. Additionally, he has expertise in structural and functional analysis of bacterial outer membrane proteins, which play a crucial role in drug resistance. Dr. Bolla is also skilled in cell culture techniques, bioinformatics, and statistical analysis for interpreting large-scale screening data. His ability to secure major research funding highlights his competence in grant writing and project management. Furthermore, his teaching and mentorship experience demonstrate his ability to train and guide students in advanced microbiology research techniques. His research skills make him a valuable asset in the fight against antimicrobial resistance, as he continues to develop innovative solutions to combat bacterial infections.

Awards and Honors

Dr. Jean Michel Bolla has been recognized for his outstanding contributions to microbiology and antibiotic resistance research. In 2007, he was awarded the Inserm-Université Interface Contract, acknowledging his excellence in research and academic collaboration. His work in antimicrobial resistance has also been recognized through significant research grants from CNRS, ANR, and FEAMPA, underscoring the impact of his studies in drug discovery and bacterial resistance mechanisms. In 2019, his Bac-Screen platform was designated an Aix-Marseille University Technological Platform, a prestigious recognition that was renewed in 2023 for its critical role in antibiotic resistance research. His contributions to the field have also led to an international patent (WO 2023/139263 A1) for a diagnostic tool to detect drug resistance. Additionally, he has been an invited speaker at leading scientific conferences, including GRS-GRC Multidrug Efflux Systems and The 3rd International Electronic Conference on Antibiotics. His expertise and dedication to advancing microbial research have positioned him as a leading scientist in his field, earning him widespread recognition and respect.

Conclusion

Dr. Jean Michel Bolla is a highly accomplished microbiologist with a strong research background in antibiotic resistance and bacterial physiology. His contributions to understanding efflux-mediated resistance in Gram-negative bacteria have had a profound impact on the field. As Director of Research at Inserm U-1261, he has demonstrated exceptional leadership, securing major research funding and spearheading innovative screening platforms for antimicrobial resistance studies. His dedication to mentoring PhD students and postdoctoral researchers underscores his commitment to advancing scientific knowledge. Through his numerous research projects, international collaborations, and conference presentations, he continues to make significant strides in addressing the global challenge of antibiotic resistance. His patent for a diagnostic tool in antimicrobial resistance showcases his ability to translate research into real-world applications. Recognized through awards and honors, Dr. Bolla is a leading expert in microbiology and antimicrobial resistance. His work has positioned him as a key figure in drug discovery and bacterial resistance research, making him a strong contender for the Best Researcher Award. His career is a testament to scientific excellence, innovation, and dedication to global health challenges.

Publications Top Notes

Title: RND Efflux Pump Induction: A Crucial Network Unveiling Adaptive Antibiotic Resistance Mechanisms of Gram-Negative Bacteria
Authors: M. Novelli, Marine; J.M. Bolla, Jean Michel
Year: 2024
Citations: 5
Title: Design and Synthesis of Novel Amino and Acetamidoaurones with Antimicrobial Activities
Authors: A. Di Maio, Attilio; H. Olleik, Hamza; É. Courvoisier-Dezord, Élise; M. Maresca, Marc; M. Robin, Maxime
Year: 2024
Citations: 1
Title: Antitubercular potential and pH-driven mode of action of salicylic acid derivatives
Authors: J. Laudouze, Janïs; T. Francis, Thomas; E. Forest, Emma; P. Santucci, Pierre; J.F. Cavalier, Jean-François
Year: 2024
Title: Synthesis and antimicrobial testing of 5-fluorouracil derivatives
Authors: M.U. Patil, Mrunal Unmesh; S. Krykun, Serhii; F. Garzino, Frédéric; J.M. Bolla, Jean Michel; M. Camplo, Michel
Year: 2023
Citations: 5
Title: The membrane-active polyaminoisoprenyl compound NV716 re-sensitizes Pseudomonas aeruginosa to antibiotics and reduces bacterial virulence
Authors: G. Wang, Gang; J.M. Brunel, Jean Michel; M. Preusse, Matthias; J.M. Bolla, Jean Michel; F. van Bambeke, Francoise
Year: 2022
Citations: 11
Title: An Original and Efficient Antibiotic Adjuvant Strategy to Enhance the Activity of Macrolide Antibiotics against Gram-Negative Resistant Strains
Authors: A. Troudi, Azza; J.M. Bolla, Jean Michel; N. Klibi, Naouel; J.M. Brunel, Jean Michel
Year: 2022
Citations: 4
Title: The polyamino-isoprenyl potentiator NV716 revives disused antibiotics against Gram-negative bacteria in broth, infected monocytes, or biofilms, by disturbing the barrier effect of their outer membrane
Authors: G. Wang, Gang; J.M. Brunel, Jean Michel; H. Rodríguez-Villalobos, Héctor; J.M. Bolla, Jean Michel; F. van Bambeke, Francoise
Year: 2022
Citations: 6
Title: Nanoarchitectonics of Electrically Activable Phosphonium Self-Assembled Monolayers to Efficiently Kill and Tackle Bacterial Infections on Demand
Authors: S. Carrara, Serena; F. Rouvier, Florent; S. Auditto, Sanjana; J.M. Bolla, Jean Michel; J.M. Raimundo, Jean Manuel
Year: 2022
Citations: 6

Vladka Čurin Šerbec | Immunology and Microbiology | Women Researcher Award

Posted on 03/12/202403/12/2024 by ScienceFather

Prof. Dr. Vladka Čurin Šerbec | Immunology and Microbiology | Women Researcher Award

Head of Research Group at Blood Transfusion Centre of Slovenia, Slovenia

Vladka Čurin Šerbec is an accomplished researcher and academic with a robust background in biochemistry, molecular biology, and immunology. With extensive experience in both academic and industrial settings, she has made significant contributions to the development of monoclonal antibodies, diagnostics, and therapeutics. Through her leadership roles, including serving as the President of the Immunology Society of Slovenia, she has influenced research in the fields of immunology and biomedicine. Her research also involves collaborations with pharmaceutical industries, leading to the development of new technologies and successful commercialization of research outcomes. Known for her mentorship of numerous students and professionals, Čurin Šerbec is a respected figure in the scientific community, contributing to the education and growth of future researchers.

Professional Profile

Education

Vladka Čurin Šerbec’s academic journey began with a BChem degree from the University of Ljubljana in 1985. She continued her studies at the same institution, obtaining a Master’s degree in Biochemistry in 1988, followed by a PhD in 1991. Throughout her education, she focused on the molecular and biochemical aspects of biology, laying the foundation for her future research in immunology and biomedicine. This strong academic background has propelled her into various prestigious positions within both academia and industry, making her a leading figure in her field.

Professional Experience

Vladka Čurin Šerbec has a distinguished career that spans several decades, beginning with her research at the Jožef Stefan Institute and the Ruđer Bošković Institute in the 1980s and 1990s. Since 1993, she has held various key positions at the Blood Transfusion Centre of Slovenia (BTCS), including Head of the Department for the Production of Diagnostic Reagents and Research, Scientific Counsellor, and Vice-President of the Supervisory Board. Additionally, she served as an Associate Professor and later a Professor at the University of Ljubljana’s Medical Faculty. Her leadership in industrial and academic collaborations has been instrumental in advancing research in immunology and biomedicine.

Research Interests

Vladka Čurin Šerbec’s research interests are centered around biochemistry, molecular biology, immunology, and the development of monoclonal antibodies for diagnostic and therapeutic purposes. Her work focuses on the production of diagnostic reagents and antibodies under GMP conditions, exploring new approaches to immunological diagnostics and treatments. Additionally, she has been involved in collaborative research with the pharmaceutical industry, contributing to the development of technologies with real-world applications. Her interest in the standardization and quality assessment of immunological diagnostics has also been pivotal to her contributions to the field.

Research Skills

Vladka Čurin Šerbec possesses a broad skill set in molecular biology, biochemistry, and immunology. Her expertise includes the development and production of monoclonal antibodies, diagnostic reagents, and research tools. She is skilled in various laboratory techniques and methodologies, including immunoassays, molecular cloning, and protein expression. Additionally, Čurin Šerbec has significant experience in project leadership, having led multiple industrial, national, and international research initiatives. Her work also involves the development of biotechnological applications, such as antibody-based diagnostics and therapeutics, in close collaboration with pharmaceutical companies.

Awards and Honors

Vladka Čurin Šerbec has received numerous awards throughout her career in recognition of her scientific achievements. Notably, she was awarded the Zois Award in 2002 for her technological innovations and contributions to the field of biochemistry. She also received the Krka Award for students in organic chemistry in 1983, highlighting her early promise as a researcher. Čurin Šerbec’s achievements have been widely acknowledged by the scientific community, and her work continues to inspire future generations of researchers. She has also been honored with leadership positions in international societies, further solidifying her reputation in the field of immunology.

Conclusion

This individual demonstrates outstanding research capabilities and leadership in the fields of biochemistry, molecular biology, and immunology. Their substantial achievements in the development of monoclonal antibodies and collaborations with industry reflect both scientific excellence and practical contributions. Their commitment to research mentoring and international collaboration further strengthens their position for recognition in research excellence. With continued focus on expanding their publication record and global research influence, they have the potential for even greater impact in the scientific community.

Publication Top Notes

Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases
- Authors: Song, F., Kovac, V., Mohammadi, B., Curin Serbec, V., Altmeppen, H.C.
- Year: 2024
- Journal: Acta Neuropathologica
- Volume: 148(1), Pages 2
Optimizing the method for expressing human monoclonal antibodies from a single peripheral blood cell from vaccinated donors
- Authors: Omejec, S., Tompa, M., Kovač, V., Šerbec, V.Č.
- Year: 2024
- Journal: Journal of Immunological Methods
- Volume: 534, Article 113747
Prion Protein: The Molecule of Many Forms and Faces
- Authors: Kovač, V., Šerbec, V.Č.
- Year: 2022
- Journal: International Journal of Molecular Sciences
- Volume: 23(3), Article 1232
- Citations: 21
Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone
- Authors: Šelb, J., Rijavec, M., Eržen, R., Lyons, J.J., Korošec, P.
- Year: 2021
- Journal: Journal of Allergy and Clinical Immunology
- Volume: 148(2), Pages 621–626.e7
- Citations: 36
Prion Proteins Without the Glycophosphatidylinositol Anchor: Potential Biomarkers in Neurodegenerative Diseases
- Authors: Kovač, V., Čurin Šerbec, V.
- Year: 2018
- Journal: Biomarker Insights
- Volume: 13
- Citations: 6
Targeting malignant brain tumors with antibodies
- Authors: Razpotnik, R., Novak, N., Curin Šerbec, V., Rajcevic, U.
- Year: 2017
- Journal: Frontiers in Immunology
- Volume: 8(SEP), Article 1181
- Citations: 57
Truncated prion protein PrP226 – A structural view on its role in amyloid disease*
- Authors: Kovač, V., Zupančič, B., Ilc, G., Plavec, J., Čurin Šerbec, V.
- Year: 2017
- Journal: Biochemical and Biophysical Research Communications
- Volume: 484(1), Pages 45–50
- Citations: 10
New monoclonal antibodies against bilitranslocase as a diagnostic tool in determining the progress of clear cell renal cell carcinoma
- Authors: Košir, A.B., Lukan, T., Kukovec, M., Šerbec, V.Č., Rajčević, U.
- Year: 2017
- Journal: Zdravniski Vestnik
- Volume: 86(5-6), Pages 177–184
Anchorless forms of prion protein – Impact of truncation on structure destabilization and prion protein conversion
- Authors: Kovač, V., Hafner-Bratkovič, I., Čurin Šerbec, V.
- Year: 2016
- Journal: Biochemical and Biophysical Research Communications
- Volume: 481(1-2), Pages 1–6
- Citations: 10
Flavonoid interaction with a chitinase from grape berry skin: Protein identification and modulation of the enzymatic activity
- Authors: Filippi, A., Petrussa, E., Rajcevic, U., Vianello, A., Braidot, E.
- Year: 2016
- Journal: Molecules
- Volume: 21(10), Article 1300
- Citations: 9

Wajiha Ahmed | Immunology and Microbiology | Women Researcher Award

Posted on 21/08/202421/08/2024 by ScienceFather

Ms. Wajiha Ahmed | Immunology and Microbiology | Women Researcher Award

Post Doctoral Fellow of Suzhou institute of Nano tech and Nano bionics, China.

Wajiha Ahmed is a distinguished researcher from Pakistan with a diverse background in biomaterials and biology. She earned her PhD from Zhejiang University, China, where she focused on immune regulation and wound healing using innovative biomaterials like chiral polymers and ROS-responsive nanofibers. Her Master’s research involved plant-derived silver nanoparticles for chemical sensing, showcasing her early commitment to impactful research. Wajiha’s significant contributions are reflected in her nine peer-reviewed publications in reputable journals, including ACS Biomaterials Science & Engineering and Journal of Biomedical Materials Research Part A. Currently serving as Assistant General Manager at Global Clinical Cura Pvt. Limited, she combines academic expertise with industry experience. Her research addresses critical health issues, particularly in wound healing for diabetic and infectious wounds, emphasizing her dedication to advancing medical science. Wajiha’s international experience and impactful research make her a strong candidate for the Best Researcher Award.

Profile

Education

Wajiha Ahmed’s educational journey reflects a strong foundation in biotechnology and biomedical sciences, coupled with advanced research experience in biomaterials. She earned her PhD from Zhejiang University, China, where she specialized in biomaterials with a focus on immune regulation and wound healing. Her doctoral research involved innovative projects such as developing ROS-responsive polymer nanofibers and exploring the impact of enantiomeric polylysine on inflammatory responses, showcasing her expertise in cutting-edge biomedical applications. Prior to her PhD, Wajiha completed her Master’s degree in Biomedical Sciences and Engineering from the National University of Sciences and Technology (NUST), Islamabad, Pakistan. Her Master’s thesis centered on the chemical sensing of carcinogens using plant-derived fluorescent flavonoids, demonstrating her ability to integrate biological and chemical sciences. Wajiha’s academic journey began with a Bachelor’s degree in Biotechnology from the Islamia University of Bahawalpur, Pakistan, where she gained a solid grounding in the life sciences.

Professional Experience

Wajiha Ahmed has a diverse professional background, blending academic and industry experience. She currently serves as the Assistant General Manager at Global Clinical Cura Pvt. Limited, a role she has held since January 2021, where she manages key clinical operations, contributing to the company’s strategic goals. Prior to this, Wajiha held academic positions, including as a Visiting Lecturer at Shifa Tameer-e-Millat University in Islamabad, Pakistan, from February 2016 to 2017, where she was involved in teaching and curriculum development. She also served as a Lecturer at Fazaia Intercollege Jinnah Camp in Islamabad from February 2016 to August 2017, and as a Teacher at Springfield Public School and College in Rawalpindi from March 2014 to 2015. These roles allowed her to hone her teaching skills and foster a deep commitment to education. Her professional experience reflects a solid foundation in both educational and managerial capacities.

Research Interest

Wajiha Ahmed’s research interests are deeply rooted in the interdisciplinary fields of biomaterials and biomedical engineering, with a particular focus on developing innovative solutions for wound healing and immune regulation. Her work spans the synthesis and characterization of advanced materials such as chiral polymers, ROS-responsive polymer nanofibers, and plant-derived silver nanoparticles. Wajiha is particularly interested in exploring the interactions between biomaterials and biological systems, aiming to enhance therapeutic outcomes in conditions such as diabetic wounds and chronic inflammations. Her PhD research on multifunctional drug-loaded nanofibers for smart wound healing and the immune modulation of bone marrow-derived macrophages highlights her dedication to addressing critical health challenges through material science. Additionally, her background in chemical sensing of carcinogens using plant-based materials underscores her commitment to environmental and health safety, making her research both impactful and socially relevant.

Research Skills

Wajiha Ahmed is an accomplished researcher with a robust set of skills in biomaterials and biomedical sciences. Her expertise lies in the synthesis and characterization of advanced nanomaterials, including chiral polymers and ROS-responsive polymer nanofibers, which she has applied to critical areas such as immune regulation and wound healing. Wajiha is proficient in various laboratory techniques, including nanoparticle synthesis, polymer grafting, and in vitro cellular assays. Her ability to design and conduct complex experiments is evident in her contributions to high-impact research projects. Additionally, she is skilled in data analysis and interpretation, employing advanced analytical tools to derive meaningful insights from experimental results. Wajiha’s research is also characterized by strong interdisciplinary collaboration, allowing her to integrate biological, chemical, and material science principles effectively. Her publications in reputable journals further reflect her dedication to advancing knowledge in the field of biomaterials.

Awards and Recognition

Wajiha Ahmed has earned recognition for her exceptional contributions to the field of biomaterials and biology. Her innovative research on immune regulation, wound healing, and chemical sensing has been published in reputable journals, highlighting her impact on advancing scientific knowledge. Wajiha’s work has been acknowledged through her role as a first and co-author in multiple peer-reviewed publications, reflecting her dedication and expertise. Her international research experience, particularly during her PhD at Zhejiang University, has further solidified her reputation as a promising researcher in her field. Additionally, Wajiha’s involvement in interdisciplinary projects and her ability to address critical health challenges, such as diabetic wound healing, underscore her commitment to research that has tangible societal benefits. While she is still in the early stages of her career, her accomplishments have already positioned her as a rising star in biomaterials research, earning her respect and recognition among her peers.

Conclusion

Wajiha Ahmed is a strong candidate for the Best Researcher Award, given her significant contributions to biomaterials research, her impressive publication record, and her international research experience. To further strengthen her candidacy, she could focus on expanding her industrial collaborations and increasing her public engagement efforts. Overall, her multidisciplinary expertise and commitment to addressing societal challenges through research make her a suitable and competitive nominee for the award.

Publications Top Notes

Bi-layered Polyurethane Nanofiber Patches with Asymmetrical Surface Prevent Postoperative Adhesion and Enhance Cardiac Repair
- Authors: Li, S., Ahmed, W., Wang, S., Zhu, Y., Gao, C.
- Year: 2024
- DOI: 10.1016/j.compositesb.2024.111668
Taking Chiral Polymers Toward Immune Regulation
- Authors: Ahmed, W., Karabaliev, M., Gao, C.
- Year: 2022
- Citations: 6
- DOI: 10.1002/pol.20220163
Influence of Enantiomeric Polylysine Grafted on Gold Nanorods on the Uptake and Inflammatory Response of Bone Marrow-Derived Macrophages in Vitro
- Authors: Ahmed, W., Zhang, H., Gao, C.
- Year: 2022
- DOI: 10.1002/jbm.a.37068
Reactive Oxygen Species-Responsive and Scavenging Polyurethane Nanoparticles for Treatment of Osteoarthritis In Vivo
- Authors: Zhang, H., Xiong, H., Ahmed, W., Fan, C., Gao, C.
- Year: 2021
- Citations: 39
- DOI: 10.1016/j.cej.2020.128147
Adaptive Antibacterial Biomaterial Surfaces and Their Applications
- Authors: Ahmed, W., Zhai, Z., Gao, C.
- Year: 2019
- Citations: 134
- DOI: 10.1016/j.mtbio.2019.100017
Design and Applications of Cell-Selective Surfaces and Interfaces
- Authors: Zhang, H., Zheng, X., Ahmed, W., Chen, Y., Gao, C.
- Year: 2018
- Citations: 35
- DOI: 10.1021/acs.biomac.8b00492

Teymoor Ghanbari | Nanogenerators | Best Researcher Award

Posted on 16/08/202416/08/2024 by ScienceFather

Prof. Teymoor Ghanbari | Nanogenerators | Best Researcher Award

Faculty Member at Shiraz University , Iran.

Prof. Teymoor Ghanbari is a distinguished Full Professor at Shiraz University, renowned for his extensive contributions to electrical engineering. His research focuses on the design, modeling, and fabrication of electrical systems, including innovative hysteresis motors and fault current limiters. Prof. Ghanbari’s work has had significant geographic impact, improving power systems and energy efficiency both within Iran and internationally. He has published over 100 journal papers, more than 50 conference papers, and holds six patents, reflecting his prolific output and influence. His awards include being ranked among the top 1% of scientists globally by WOS and ESI, and he has been recognized as an outstanding professor in research multiple times. Prof. Ghanbari’s expertise extends to applied research in power system management, with practical projects enhancing reliability and safety. His notable achievements and global recognition highlight his exceptional contributions to the field of electrical engineering.

Profile

Scopus Profile

Education

Prof. Teymoor Ghanbari’s educational journey reflects his deep commitment to electrical engineering. He earned his PhD in Electrical Engineering from Shiraz University in October 2012. His doctoral dissertation, titled “Initial Management of Transients in Microgrids, Challenges and Strategies,” was supervised by Prof. Ebrahim Farjah, Dr. Haidar Samet, Prof. Mahmud Fotoohi, and Dr. Mohammad Mohammadi. Prior to his PhD, Prof. Ghanbari completed his Master’s degree at Shahrood University of Technology in October 2007, where he focused on the “Analysis of Dynamic Behaviors of Hysteresis Motor Using a Suitable Model,” under the guidance of Prof. Ahmad Darabi. His academic foundation began with a Bachelor’s degree in Electrical Engineering from Sh. Rajaee University, completed in May 1997. This rigorous educational background has laid the groundwork for his innovative contributions to the field of electrical engineering.

Professional Experience

Prof. Teymoor Ghanbari, a Full Professor at Shiraz University, has a distinguished career in electrical engineering, marked by significant contributions to power systems and electrical motor technology. His professional journey began with the invention of several types of hysteresis motors and the development of fault current limiters for AC and DC power systems. He has led projects on power systems components monitoring, transient limiters, and energy efficiency improvements. Notable achievements include designing a battery management system for SOHA satellite and assessing fault ride-through capabilities for PV farms. Prof. Ghanbari’s leadership extends to academic and conference roles, including serving as a scientific chair at major international conferences. His expertise is recognized globally, with multiple awards and a strong publication record, underscoring his impact on both theoretical and applied aspects of electrical engineering.

Research Interest

Prof. Teymoor Ghanbari’s research interests are primarily centered around electrical engineering, focusing on the modeling, design, and fabrication of electrical systems and components. His work encompasses a wide range of areas, including the invention of various hysteresis motors and the development of fault current limiters for both AC and DC power systems. Prof. Ghanbari’s research also delves into power system monitoring, failure detection, and the implementation of advanced protection approaches for electric motors, transformers, and converters. His innovative projects include designing transient limiters, developing battery management systems, and assessing the fault ride-through capabilities of large-scale photovoltaic farms. With a strong emphasis on practical applications and real-world problem-solving, Prof. Ghanbari’s research aims to enhance the reliability, efficiency, and safety of electrical systems and power management technologies.

Research Skills

Prof. Teymoor Ghanbari exhibits exceptional research skills in the field of electrical engineering, showcasing a profound expertise in modeling, design, and fabrication of advanced electrical systems. His skills include the development of innovative hysteresis motors and fault current limiters, demonstrating a strong grasp of complex engineering principles and applications. Prof. Ghanbari excels in applied research, with a notable ability to translate theoretical concepts into practical solutions for power systems management and fault detection. His proficiency extends to designing transient limiters and monitoring systems, reflecting his capability in addressing real-world challenges in energy efficiency and system reliability. Additionally, his extensive publication record and patent portfolio highlight his ability to conduct rigorous research and contribute valuable knowledge to the field. Prof. Ghanbari’s skills are further evidenced by his leadership roles in academic conferences and his mentorship of graduate students, underscoring his commitment to advancing research and fostering innovation.

Parasitology and Infectious Diseases

Prof. Ghanbari’s research does not focus on parasitology or infectious diseases. His expertise is centered around electrical engineering and power systems, with no direct contributions to these fields.

Awards and Recognition

Prof. Ghanbari has received several prestigious awards and recognitions, including being ranked among the top 1% of scientists globally by WOS and ESI. He has also been recognized as an outstanding professor in research at Shiraz University and Fars province. His inclusion in the World’s Top 2% Scientists List by Stanford University and Elsevier further highlights his significant impact in his field.

Conclusion

Prof. Teymoor Ghanbari’s extensive research contributions, applied innovations, and global impact make him a strong candidate for the Best Researcher Award. His work in electrical engineering, particularly in developing advanced power system technologies and fault detection methods, demonstrates his leadership and dedication to advancing the field. His numerous awards and recognitions underscore his exceptional achievements and contributions to the scientific community.

Publications Top Notes

Fault ride through enhancement of large-scale solar plants using distributed converters
- Authors: S.M.H. Mousavi, T. Ghanbari, E. Farjah, A. Mehraban
- Year: 2024
Stator winding fault detection of induction motors using fast Fourier transform on rotor slot harmonics and least square analysis of the Park’s vectors
- Authors: T. Ghanbari, A. Mehraban
- Year: 2024
AI-Based Control of Storage Capacity in High-Power-Density Energy Storage Systems, Used in Electric Vehicles
- Authors: A. Mehraban, T. Ghanbari, E. Farjah
- Year: 2024
- Citations: 5
Adaptation of Triboelectric Nanogenerators to the Integrated Energy Storages by a Textured Multi-Segment Structure
- Authors: N. Sharif, T. Ghanbari, Z. Hosseini, K. Shahbazi, A. Mehraban
- Year: 2024
Integrated Optimal Energy Management and Sizing of Hybrid Battery/Flywheel Energy Storage for Electric Vehicles
- Authors: A. Mehraban, E. Farjah, T. Ghanbari, L. Garbuio
- Year: 2023
- Citations: 4
Application of a Rogowski Coil Sensor for Separating Internal and External Partial Discharge Pulses in Power Transformers
- Authors: S. Sharifinia, M. Allahbakhshi, T. Ghanbari, H. Pakniat
- Year: 2023
- Citations: 2
Fault Detection in DC Microgrid: A Transient Monitoring Function-Based Method
- Authors: M.A. Jarrahi, H. Samet, T. Ghanbari
- Year: 2023
- Citations: 4
A Modular Unipolar/Bipolar High-Voltage Pulse Generator Suitable for High Resistive Load
- Authors: M. Taherian, S. Roshan, M. Allahbakhshi, E. Farjah, T. Ghanbari
- Year: 2023
- Citations: 1
Dynamic Polynomial Models With ARMA Coefficients Used for Modeling the DC Series Arc Fault in Photovoltaic Systems
- Authors: M. Jalil, H. Samet, T. Ghanbari
- Year: 2023
- Citations: 2
Partial shading detection and hotspot prediction in photovoltaic systems based on numerical differentiation and integration of the P − V curves
- Authors: M. Khodapanah, T. Ghanbari, E. Moshksar, Z. Hosseini
- Year: 2023
- Citations: 9

Tsuksa Nabekura | Immunology and Microbiology | Best Researcher Award

Posted on 16/08/202416/08/2024 by ScienceFather

Prof. Tsukasa Nabekura | Immunology and Microbiology | Best Researcher Award

Ph.D. at Aichi Cancer Center Research Institute , Japan.

Dr. Tsukasa Nabekura is a prominent immunologist known for his groundbreaking research on natural killer (NK) cells. Since 2008, he has made significant contributions to understanding NK cell receptors and their roles in immune responses to viral infections, cancer, and tissue injury. His work has led to key insights into NK cell differentiation, function, and memory, as evidenced by his publications in high-impact journals like Immunity and Journal of Experimental Medicine. Dr. Nabekura’s research has global significance, with collaborations spanning institutions such as the University of California, San Francisco, and the University of Tsukuba, Japan. His achievements have been recognized with prestigious awards, including the Young Investigator Award from the Japanese Society of Immunology and the BEST FACULTY MEMBER award. Dr. Nabekura’s research continues to advance the field of immunology, with potential implications for therapeutic strategies in cancer and infectious diseases.

Profile

Scopus Profile

Education

Dr. Tsukasa Nabekura’s educational background reflects a strong foundation in biological and medical sciences. He completed his Bachelor of Science in Biology in March 2003, followed by a Master of Arts in Medical Science in March 2005, both from the University of Tsukuba, Japan. Dr. Nabekura then pursued a Ph.D. in Medicine at the same institution, graduating in March 2008. His commitment to advancing his expertise continued with postdoctoral research at the University of Tsukuba, where he focused on Immunology and completed his postdoc in October 2011. Further enhancing his qualifications, he undertook an additional postdoctoral fellowship at the University of California, San Francisco, from October 2014. This extensive educational journey equipped Dr. Nabekura with a deep understanding of immunology and cell biology, setting the stage for his influential research on natural killer (NK) cells and their roles in immune responses.

Professional Experience

Dr. Tsukasa Nabekura has built a distinguished career in immunology with a focus on natural killer (NK) cells. After completing his postdoctoral research in immunology at the University of California, San Francisco, he returned to Japan as an Assistant Professor in the Life Science Center of Tsukuba Advanced Research Alliance at the University of Tsukuba. His expertise led him to roles at the Life Science Center for Survival Dynamics and the Division of Immune Response at the Aichi Cancer Center Research Institute. Dr. Nabekura’s professional trajectory reflects a strong commitment to advancing immunological research and understanding NK cell biology. His career is marked by his significant contributions to the field through his research on NK cell function and memory, collaborative efforts with leading scientists, and the recognition he has received through various awards and honors.

Research Interest

Dr. Tsukasa Nabekura’s research interests center on the intricate roles of natural killer (NK) cells in immune responses. Since 2008, his work has delved into how NK receptors and associated molecules influence innate and adaptive immunity against viral infections, cancer, and acute tissue injury. His research has elucidated the pivotal role of DNAX accessory molecule-1 (DNAM-1) in NK cell memory differentiation and its impact on acute graft-versus-host disease. Dr. Nabekura has also investigated how activating receptors enhance NK cell functions and memory during infections. His recent studies focus on the regulatory functions of Themis2 in NK cell memory and antitumor activity. By exploring these aspects, Dr. Nabekura aims to advance our understanding of immune responses and contribute to the development of new therapeutic strategies for treating cancer and viral diseases.

Research Skills

Dr. Tsukasa Nabekura possesses a diverse range of advanced research skills that underscore his expertise in immunology. His proficiency in cellular and molecular immunology is evident from his extensive work on natural killer (NK) cells, including their receptors and associated molecules. He has demonstrated exceptional skills in experimental design and execution, particularly in studying NK cell function during viral infections and cancer. Dr. Nabekura’s expertise extends to cutting-edge techniques in cell biology, including flow cytometry, immunohistochemistry, and cytokine profiling. His ability to collaborate with leading researchers and institutions further highlights his strong skills in cross-disciplinary research and team-based science. Additionally, Dr. Nabekura’s experience in securing research fellowships and grants reflects his competence in research proposal development and project management. His comprehensive approach to studying immune responses and his successful publication record illustrate his high level of research acumen and dedication to advancing scientific knowledge.

Awards and Recognition

Dr. Nabekura has received numerous awards, including the Young Investigator Award from the Japanese Society of Immunology and the BEST FACULTY MEMBER award at the University of Tsukuba. These accolades reflect his outstanding contributions and recognition within the scientific community.

Conclusion

Dr. Tsukasa Nabekura’s exceptional research on NK cells and immune responses demonstrates his profound impact on the field of immunology. His contributions to understanding immune mechanisms, his collaborative efforts, and his recognition through various awards underscore his suitability for the Research for Best Researcher Award. His work continues to advance scientific knowledge and has the potential to influence therapeutic strategies for infectious diseases and cancer.

Publications Top Notes

THEMIS2 Impairs Antitumor Activity of NK Cells by Suppressing Activating NK Receptor Signaling
- Authors: E.A. Deborah, T. Nabekura, K. Shibuya, A. Shibuya
- Year: 2024
Themis2 regulates natural killer cell memory function and formation
- Authors: T. Nabekura, E.A. Deborah, S. Tahara, M. Muratani, A. Shibuya
- Year: 2023
- Citations: 4
DNAM-1 Immunoreceptor Protects Mice from Concanavalin A-Induced Acute Liver Injury by Reducing Neutrophil Infiltration
- Authors: S. Matsuo, T. Nabekura, K. Matsuda, K. Shibuya, A. Shibuya
- Year: 2023
- Citations: 1
Liver type 1 innate lymphoid cells lacking IL-7 receptor are a native killer cell subset fostered by parenchymal niches
- Authors: T. Asahi, S. Abe, G. Cui, H. Ohno, K. Ikuta
- Year: 2023
- Citations: 4
The CD16 and CD32b Fc-gamma receptors regulate antibody-mediated responses in mouse natural killer cells
- Authors: O.A. Aguilar, M.D.R. Gonzalez-Hinojosa, J.S. Arakawa-Hoyt, T. Nabekura, L.L. Lanier
- Year: 2023
- Citations: 8
Early reactivation of clustered genes on the inactive X chromosome during somatic cell reprogramming
- Authors: S. Aizawa, K. Nishimura, G.S. Mondejar, Y. Hayashi, K. Hisatake
- Year: 2022
- Citations: 3
Erratum: Corrigendum to selective expression of a C-type lectin receptor, Clec12b, on skin mast cells
- Authors: A. Iijima, K. Kanemaru, Y. Wang, S. Tahara-Hanaoka, A. Shibuya
- Year: 2021
Selective expression of a C-type lectin receptor, Clec12b, on skin mast cells
- Authors: A. Iijima, K. Kanemaru, Y. Wang, S. Tahara-Hanaoka, A. Shibuya
- Year: 2021
Type 1 innate lymphoid cells: Soldiers at the front line of immunity
- Authors: T. Nabekura, A. Shibuya
- Year: 2021
- Citations: 17
ILC1: guardians of the oral mucosa against enemy viruses
- Authors: T. Nabekura, A. Shibuya
- Year: 2021
- Citations: 7

Svetlana Pleskova | Immunology and Microbiology | Best Researcher Award

Posted on 22/07/2024 by ScienceFather

Prof. Svetlana Pleskova | Immunology and Microbiology | Best Researcher Award

Head of the laboratory of Nizhny Novgorod State University named after N.I. Lobachevsky, Russia.

Professional Profiles:

Education

Svetlana Pleskova holds a Doctorate in Biotechnology, Physical, and Analytical Chemistry (Physiology, Allergology, and Immunology) from Alekseev Technical State University, Nizhni Novgorod, completed between 2007 and 2009. She earned her PhD in Physiology, Allergology, and Immunology from the Department of Microbiology and Immunology at the Medical State Academy in Nizhni Novgorod from 1998 to 2001. Svetlana also holds a Bachelor’s degree in Molecular Biology and Immunology from Lobachevsky Nizhni Novgorod State University, graduating with honors (cum laude) in 1998. Her educational journey began at Medical School in Nizhni Novgorod, where she graduated with honors (cum laude) in 1992.

Professional Experience

Professor Svetlana Pleskova is a distinguished researcher in nanotechnology and biotechnology. Since 2016, she has been a Professor at Alekseev Nizhny Novgorod Technical State University and leads the scanning probe microscopy laboratory at Lobachevsky Nizhny Novgorod State University. Her research focuses on septicemia, septicopiemia, and antibiotic resistance diagnostics. Svetlana previously led the Nanobiotechnology and Atomic Force Microscopy group, focusing on nanoparticle biocompatibility. From 2009 to 2013, she was a Professor and Leading Research Fellow at Nizhny Novgorod Technical State University, researching nanoparticle-blood cell interactions and TiO2-nanofilms. She has also worked under Prof. Solioz in Switzerland and Prof. Lesniewska in France, creating nanopumps and studying cell interactions. Her earlier roles include Associate Professor, Assistant, and Researcher in microbiology, immunology, and biotechnology.

Research Interest

Professor Svetlana Pleskova’s research interests lie at the intersection of nanotechnology, biotechnology, and medical sciences. She focuses on studying septicemia and septicopiemia through advanced microscopy techniques such as atomic force microscopy, scanning ion-conducting microscopy, and scanning electron microscopy. Her work explores the adhesion contacts between endothelial cell receptors and blood cells modified by bacteria and nanoparticles. Additionally, she is dedicated to the development of nanotips for real-time antibiotic resistance diagnostics. Svetlana is also interested in the biocompatibility of nanoparticles, including quantum dots, nanoscale luminophores, and magnetic nanoparticles, as well as the bactericidal properties of TiO2-nanofilms. Her diverse research aims to advance diagnostic and therapeutic approaches in healthcare.

Award and Honors

Professor Svetlana Pleskova has received numerous awards and honors throughout her distinguished career. She has been recognized with 14 awards and grants, including 6 where she served as the head. Her accolades reflect her significant contributions to the fields of nanotechnology and biotechnology. Svetlana is an esteemed member of the Federation of Societies of Biochemistry and Molecular Biology and the Federation of Biotechnology. Additionally, she serves as a reviewer for the Russian Science Foundation and the Research Institute of FGBNU Rinkc, further highlighting her expertise and influence in her field.

Research Skills

Professor Svetlana Pleskova possesses extensive research skills in nanotechnology, biotechnology, and molecular biology. She is proficient in atomic force microscopy, scanning ion-conducting microscopy, and scanning electron microscopy, which she utilizes to study septicemia, septicopiemia, and adhesion contacts between endotheliocytes and blood cells. Svetlana has expertise in creating nanotips for real-time diagnostics of antibiotic resistance and developing nanopumps for heavy metals. Her work includes the study of biocompatibility of nanoparticles, quantum dots, nanoscale luminophores, and magnetic nanoparticles. Additionally, she has experience in using ELISA for diagnostics and in the physiological modification of the complement system.

Publications

“Nanomotion of bacteria to determine metabolic profile”
- Authors: Pleskova, S.N., Lazarenko, E.V., Bezrukov, N.A., Dokukin, M.E., Surodin, S.I.
- Journal: Nanotechnology and Precision Engineering
- Year: 2024
- Citations: 0
“A Study of EA.hy926 Endothelial Cells Using Atomic Force and Scanning Ion Conductance Microscopy”
- Authors: Pleskova, S.N., Bezrukov, N.A., Gorshkova, E.N., Bobyk, S.Z., Lazarenko, E.V.
- Journal: Cell and Tissue Biology
- Year: 2024
- Citations: 0
“Exploring the Process of Neutrophil Transendothelial Migration Using Scanning Ion-Conductance Microscopy”
- Authors: Pleskova, S.N., Bezrukov, N.A., Gorshkova, E.N., Bobyk, S.Z., Lazarenko, E.V.
- Journal: Cells
- Year: 2023
- Citations: 1
“ROS Production by a Single Neutrophil Cell and Neutrophil Population upon Bacterial Stimulation”
- Authors: Pleskova, S.N., Erofeev, A.S., Vaneev, A.N., Bezrukov, N.A., Lazarenko, E.V.
- Journal: Biomedicines
- Year: 2023
- Citations: 0
“A New Method for Express Detection of Antibiotic Resistance”
- Authors: Pleskova, S.N., Lazarenko, E.V., Sudakova, I.S., Kriukov, R.N., Bezrukov, N.A.
- Journal: Applied Biochemistry and Microbiology
- Year: 2023
- Citations: 2
“Study of EA.hy926 Endothelial Cells by Atomic Force and Scanning Ion-Conductance Microscopy”
- Authors: Pleskovaa, S.N., Bezrukov, N.A., Gorshkova, E.N., Bobyk, S.Z., Lazarenkoa, E.V.
- Journal: Tsitologiya
- Year: 2023
- Citations: 0
“Differences in bacteria nanomotion profiles and neutrophil nanomotion during phagocytosis”
- Authors: Pleskova, S.N., Lazarenko, E.V., Bezrukov, N.A., Boryakov, A.V., Kriukov, R.N.
- Journal: Frontiers in Microbiology
- Year: 2023
- Citations: 4
“Staphylococcus aureus Causes the Arrest of Neutrophils in the Bloodstream in a Septicemia Model”
- Authors: Pleskova, S.N., Bobyk, S.Z., Kriukov, R.N., Gorshkova, E.N., Bezrukov, N.A.
- Journal: Microorganisms
- Year: 2022
- Citations: 1
“High-Resolution Scanning Ion-Conductance Microscopy for the Study of Blood Cell Morphology and Rigidity”
- Authors: Bezrukov, N.A., Pleskova, S.N., Bobyk, S.Z., Boryakov, A.V.
- Journal: Opera Medica et Physiologica
- Year: 2022
- Citations: 0
“Nanovibrations of Atomic Force Microscope Cantilevers as a System for Real Time Detection of Antibiotic Resistance in Bacteria”
- Authors: Pleskova, S.N., Fomichev, O.I., Kriukov, R.N., Sudakova, I.S.
- Journal: Biophysics (Russian Federation)
- Year: 2021
- Citations: 2

Muhammad Adnan Shereen | Immunology Award | Best Researcher Award

Posted on 19/03/2024 by ScienceFather

Dr. Muhammad Adnan Shereen | Immunology Award | Best Researcher Award

Research Associate at Feinbeg School of Medicine, Northwestern University, Chicago, IL, USA

Dr. Muhammad Adnan Shereen is a highly accomplished researcher and educator with expertise in microbiology, virology, immunology, and molecular biology. He completed his Ph.D. in Microbiology (Virology) from Wuhan University, China, focusing on the dysregulation of astrocytic genes by the Zika virus. Dr. Shereen has received several prestigious awards and recognitions for his academic achievements, including being ranked among the top 2% most influential scientists in the world by Stanford University. He has published extensively on various aspects of virology and infectious diseases, including the COVID-19 pandemic. Dr. Shereen’s research interests include neurotropic viruses, host-pathogen interactions, and the development of therapeutic options for viral infections. He has a strong background in scientific skills, including culturing and identifying pathogenic microbes, sequencing, animal modeling, and various molecular techniques. Dr. Shereen has also gained teaching experience and has been involved in research supervision at multiple institutions, demonstrating his commitment to education and academic excellence.

Professional Profiles:

Education:

Dr. Muhammad Adnan Shereen pursued his Ph.D. in Microbiology (Virology) from September 2017 to June 2021 at the State Key Laboratory of Virology, Department of Microbiology, College of Life Sciences, Wuhan University, China. His dissertation focused on the dysregulation of astrocytic genes involved in neurodevelopment by the Zika virus. Prior to his Ph.D., Dr. Shereen completed his M.Phil. in Microbiology from September 2013 to June 2015 at the Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan. His M.Phil. dissertation involved the synthesis and characterization of Miltefosine Loaded Thiolated Nanoparticles for Leishmaniasis Therapy. He obtained his Bachelor of Science (Hons) in Microbiology from The University of Peshawar, Pakistan, from 2009 to 2013. Additionally, Dr. Shereen completed his Higher Secondary School Certificate (Pre-Medical) from Peshawar Model Degree College, Peshawar, Pakistan, from 2005 to 2007.

Professional Experience:

Dr. Muhammad Adnan Shereen is currently a Research Associate/Postdoctoral at the Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, USA. He also serves as a Research Lecturer at Kohsar University of Murree, Pakistan, where he supervises research and teaches various subjects in the Department of Microbiology. Previously, he worked as a Research Lecturer at the University of Haripur, Pakistan, where he also supervised research and taught microbiology-related subjects. During his Ph.D., Dr. Shereen worked as a Research Associate in Professor Jianguo Wu’s lab at the State Key Laboratory of Virology. He has also participated in the CSCB Training Course on Mouse Genetics and Phenotyping, organized by the Model Animal Research Center, Nanjing University, China, and the Chinese Society for Cell Biology. Earlier in his career, Dr. Shereen served as a Demonstrator at Jinnah Medical College, Peshawar, Pakistan, where he taught General Bacteriology, Immunology, and Parasitology. He also gained valuable experience as an Internee at Govt. Lady Reading Hospital, Peshawar, Pakistan, where he worked in the Pathology department, focusing on microbiology, serology, PCR, and ELISA.

Research Interest:

Dr. Muhammad Adnan Shereen possesses a diverse skill set in the field of microbiology and related disciplines. His expertise includes microbiology, virology, molecular biology, and immunology, reflecting a comprehensive understanding of microbial pathogens and their interactions with host organisms. Dr. Shereen is proficient in cell and tissue culture technology, which is crucial for studying the behavior of cells in controlled environments. He has experience in isolating primary cells, a fundamental technique in cell biology and immunology research. His knowledge extends to innate immunity, the body’s first line of defense against pathogens, and the complex interactions between hosts and pathogens. Dr. Shereen is skilled in animal modeling, an essential tool for studying diseases and testing potential treatments in vivo. Additionally, he is adept at bioinformatic analysis, enabling him to process and interpret complex biological data. Overall, Dr. Shereen’s broad range of skills makes him a valuable asset in research settings focused on microbiology and related fields.

Awards and Recognitions:

Dr. Muhammad Adnan Shereen has been recognized for his outstanding contributions and achievements in the field of microbiology and virology. He was ranked among the top 2% most influential scientists in the world by Stanford University in both 2022 and 2023, highlighting the impact of his research and expertise. He was awarded the Chinese Government Scholarship under CSC NO. 2016GXYC42 for his Ph.D. studies, receiving a fully funded scholarship from 2017 to 2021. This prestigious scholarship reflects his academic excellence and dedication to research. Dr. Shereen’s academic achievements were further acknowledged by Wuhan University, where he was the First Prize Winner in Academic Achievement for the year 2020. He also won the “Virology Youth Innovation Award” in 2021 for the highest number of publications during his Ph.D. In recognition of his efforts during the COVID-19 pandemic, Dr. Shereen was honored as one of the “Wuhan University 8 Outstanding Individuals to Fight against Coronavirus,” highlighting his commitment to scientific advancement and public health. He has also received several other awards, including the “Excellent International Student Scholarship for the Year 2018” and the “CSCB Training Course on Mouse Genetics and Phenotyping” certificate, demonstrating his continuous pursuit of excellence in academia and research. Additionally, Dr. Shereen has been acknowledged for his academic prowess, standing as the 2nd position holder in his M.Phil. batch from 2013 to 2015. His acceptance and invitation letters for Ph.D. programs at Huazhong University of Science and Technology and Wuhan University further attest to his academic standing and research potential.

Skills:

Dr. Muhammad Adnan Shereen possesses excellent scientific skills, particularly in Microbiology, Virology, Immunology, and Molecular Biology. He is proficient in culturing and identifying pathogenic microbes, primary cell isolation, various microscopy techniques, sequencing, animal modeling, and molecular biology techniques such as PCRs, blotting assays, and ELISA. Dr. Shereen is also skilled in DNA, RNA, protein, and plasmid extractions, transfection, synthesis of biomaterials, and drug-loaded nanoparticles. His expertise makes him a valuable researcher in biomedical sciences.

Publications:

COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses
- Authors: MA Shereen, S Khan, A Kazmi, N Bashir, R Siddique
- Year: 2020
- Citations: 5591
Emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2: biology and therapeutic options
- Authors: S Khan, R Siddique, MA Shereen, A Ali, J Liu, Q Bai, N Bashir, M Xue
- Year: 2020
- Citations: 436
Impact of coronavirus outbreak on psychological health
- Authors: S Khan, R Siddique, H Li, A Ali, MA Shereen, N Bashir, M Xue
- Year: 2020
- Citations: 316
HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19
- Authors: M Tian, W Liu, X Li, P Zhao, MA Shereen, C Zhu, S Huang, S Liu, X Yu, …
- Year: 2021
- Citations: 151
STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection
- Authors: W Wang, D Hu, C Wu, Y Feng, A Li, W Liu, Y Wang, K Chen, M Tian, …
- Year: 2020
- Citations: 126
Novel coronavirus: how things are in Wuhan
- Authors: S Khan, G Nabi, G Han, R Siddique, S Lian, H Shi, N Bashir, A Ali, …
- Year: 2020
- Citations: 85
The spread of novel coronavirus has created an alarming situation worldwide
- Authors: S Khan, R Siddique, A Ali, Q Bai, Z Li, H Li, MA Shereen, M Xue, G Nabi
- Year: 2020
- Citations: 71
EV71 infection induces neurodegeneration via activating TLR7 signaling and IL-6 production
- Authors: Z Luo, R Su, W Wang, Y Liang, X Zeng, MA Shereen, N Bashir, Q Zhang, …
- Year: 2019
- Citations: 68
Breastfeeding risk from detectable severe acute respiratory syndrome coronavirus 2 in breastmilk
- Authors: C Zhu, W Liu, H Su, S Li, MA Shereen, Z Lv, Z Niu, D Li, F Liu, Z Luo, …
- Year: 2020
- Citations: 60
The comparative superiority of IgM-IgG antibody test to real-time reverse transcriptase PCR detection for SARS-CoV-2 infection diagnosis
- Authors: R Liu, X Liu, H Han, MA Shereen, Z Niu, D Li, F Liu, K Wu, Z Luo, C Zhu
- Year: 2020
- Citations: 53